IP Library Granted Patent US 7,402,159
Granted Patent B2
US 7,402,159 · App. 10/790,625 · Granted Jul 22, 2008

System and method for positioning a patient for laser surgery

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,402,159
App. No.
10/790,625
Granted
Jul 22, 2008
Kind
B2
Abstract

A system for positioning the eye of a patient, relative to a stationary surgical laser unit, includes a chair for moving the patient. An eye stabilizing element is held against the eye, with a tapered receptacle extending outwardly therefrom. Also, an alignment device with a tapered tip is mounted on the surgical laser unit. In operation, the patient is moved to engage the receptacle of the eye stabilizing element with the tip of the alignment device, to thereby align the patient's eye with the surgical laser unit for laser surgery.

Claims (44)

1. A system for positioning an eye of a patient for laser surgery which comprises:

a surgical laser unit for generating a laser beam;

an eye stabilizing element formed with a receptacle;

a means for holding said eye stabilizing element in contact with the anterior surface of the cornea of the eye to project said receptacle outwardly therefrom;

an alignment device, mounted on said surgical laser unit, wherein said alignment device is formed with a tip, and further wherein said tip is dimensioned for mating engagement with said receptacle of said eye stabilizing element;

at least one pressure sensor, mounted on said surgical laser unit, for measuring interactive forces between said alignment device and said eye stabilizing element;

a means for determining pressures exerted on the eye using said measured interactive forces; and

a means for moving the patient and said eye stabilizing element into engagement with said alignment device, for positioning the eye of the patient at a predetermined location relative to said surgical laser unit for laser surgery.

2. A system as recited in claim 1 wherein the receptacle of said eye stabilizing element is tapered, and further wherein the tip of said alignment device is tapered and dimensioned for precisely engaging with the tapered receptacle of said eye stabilizing element.

3. A system as recited in claim 1 which further comprises a plurality of light sources for illuminating the eye, wherein said light sources create an observable pattern of reflected light, and further wherein said observable pattern of reflected light can be compared to a predetermined pattern of light for verifying the positioning of the eye.

4. A system as recited in claim 1 wherein said moving means is a chair having a motorized control assembly for reconfiguring and moving said chair.

5. A system as recited in claim 1 wherein said eye stabilizing element is formed with a primary vacuum fitting, and further wherein the holding means

of the system comprises:

a primary vacuum line connected to said primary vacuum fitting; and

a primary vacuum pump in fluid communication with said primary vacuum line.

6. A system as recited in claim 5 which further comprises a means for maintaining the engagement between said alignment device and said eye stabilizing element.

7. A system as recited in claim 6 wherein the alignment device has a secondary vacuum fitting, and wherein said maintaining means comprises:

a secondary vacuum line attached to said secondary vacuum fitting;

a secondary vacuum pump in fluid communication with said secondary vacuum line; and,

a means for controlling a suction force induced by said vacuum pump, for maintaining a proper engagement between said eye stabilizing element and said alignment device.

8. A system as recited in claim 1 wherein said alignment device further comprises a mounting ring having a center point, and further wherein a first pressure sensor, a second pressure sensor, and a third pressure sensor are mounted on said surgical laser unit equidistant from said center point of said mounting ring, and equidistant from each other.

9. A method for positioning an eye of a patient for laser surgery which comprises the steps of:

holding an eye stabilizing element in contact with the anterior surface of the eye, said eye stabilizing element being formed with a receptacle, with said receptacle extending outwardly from the eye when said eye stabilizing element is held thereon;

mounting an alignment device on a surgical laser unit, wherein said alignment device is formed with a tip, said tip being dimensioned for mating engagement with said receptacle of said eye stabilizing element;

moving said eye stabilizing element into engagement with said alignment device to position the eye of the patient at a predetermined location relative to said surgical laser unit for laser surgery;

monitoring at least one pressure sensor mounted on said surgical laser unit, wherein said pressure sensor measures the interactive forces between said alignment device and said eye stabilizing element; and

determining pressures exerted on the eve using said measured interactive forces.

10. A method as recited in claim 9 which further comprises the steps of:

illuminating the eye with a plurality of light sources;

observing a pattern of reflected light; and,

comparing said pattern of reflected light to a predetermined pattern of light for verifying the positioning of the eye.

11. A method as recited in claim 9 wherein said holding step includes activating a primary vacuum pump to evacuate a vacuum channel formed in said eye stabilizing element, wherein the evacuation of said vacuum channel creates a suction force between said eye stabilizing element and the eye.

12. A method as recited in claim 9 wherein said moving step includes activating a motorized control assembly mounted in a chair, to move and reconfigure said chair.

13. A method as recited in claim 9 wherein said alignment device further comprises a mounting ring having a center point, and further wherein a first pressure sensor, a second pressure sensor, and a third pressure sensor are mounted on said surgical laser unit equidistant from said center point of said mounting ring, and equidistant from each other.

14. A system for positioning an eye of a patient for laser surgery which comprises:

a surgical laser unit for generating a laser beam;

an eye stabilizing element formed with a receptacle;

a means for holding said eye stabilizing element in contact with the anterior surface of the cornea of the eye to project said receptacle outwardly therefrom;

an alignment device, mounted on said surgical laser unit, wherein said alignment device is formed with a tip, and further wherein said tip is dimensioned for mating engagement with said receptacle of said eye stabilizing element;

a means for moving the patient and said eye stabilizing element into engagement with said alignment device, for positioning the eye of the patient at a predetermined location relative to said surgical laser unit for laser surgery; and

a plurality of light sources for illuminating the eye, wherein said light sources create an observable pattern of reflected light, and further wherein said observable pattern of reflected light can be compared to a predetermined pattern of light for verifying the positioning of the eye.

15. A system as recited in claim 14 which further comprises:

at least one pressure sensor, mounted on said surgical laser unit, for measuring interactive forces between said alignment device and said eye stabilizing element; and,

a means for determining pressures exerted on the eye using said measured interactive forces.

Assignments (12)
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 073637/0001 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMA POLAND SPOLKA Z ORGANICZONA ODPOWIEDZIALNOSCIA; VALEANT SP. Z.O.O.
Reel/Frame 073637/0222 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 045444/0634) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; LABORATOIRE CHAUVIN S.A.S.; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 061872/0295 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 057821/0800) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: TECHNOLAS PERFECT VISION GMBH; BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 061884/0514 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 036400/0711) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; TECHNOLAS PERFECT VISION GMBH
Reel/Frame 061775/0826 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 045444/0299) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES; PF CONSUMER HEALTHCARE 1 LLC; LABORATOIRE CHAUVIN S.A.S.
Reel/Frame 061779/0001 →
SECURITY INTEREST Recorded Oct 5, 2021
From: BAUSCH & LOMB IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057821/0800 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jul 3, 2019
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT PHARMACEUTICALS LUXEMBOURG S.À R.L.; VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA; VALEANT SP. Z O. O.
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 049672/0652 →
SECURITY INTEREST Recorded Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
SECURITY INTEREST Recorded Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
SECURITY INTEREST Recorded Jul 19, 2017
From: TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043251/0910 →
SECURITY AGREEMENT Recorded Aug 20, 2015
From: TECHNOLAS PERFECT VISION GMBH; DR. GERHARD MANN CHEM-PHARM. FABRIK GMBH
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 036400/0711 →